Elke Van Craenenbroeck

TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1

Hilde Azijn, Ilse Tirry, Johan Vingerhoets et al. · Antimicrobial Agents and Chemotherapy · 2009 · 294 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling

Hans Vermeiren, Elke Van Craenenbroeck, P. Alen et al. · Journal of Virological Methods · 2007 · 109 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Determination of Clinically Relevant Cutoffs for HIV-1 Phenotypic Resistance Estimates Through a Combined Analysis of Clinical Trial and Cohort Data

Bart Winters, Julio Montaner, P. Richard Harrigan et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 35 citations

Medicine, Pharmacokinetics, Pharmacology +17

Fluorescence Fluctuation Analysis for the Study of Interactions between Oligonucleotides and Polycationic Polymers

Elsa Van Rompaey, Yan Chen, Joachim D. Müller et al. · Biological Chemistry · 2001 · 30 citations · Full text

Natural Sciences, Biochemistry, Chemistry +15

Clinical cut-offs for HIV-1 phenotypic resistance estimates: Update based on recent pivotal clinical trial data and a revised approach to viral mixtures

Bart Winters, Elke Van Craenenbroeck, Koen Van der Borght et al. · Journal of Virological Methods · 2009 · 23 citations

Life Sciences, Infectious Diseases, Microbiology +11